MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer

Experimental Dermatology

Volumn 18, Issue 12, 2009, Pages 1044-1052

  Boyd, Sonja ^a   Virolainen, Susanna ^a   Pärssinen, Jenita ^a   Skoog, Tiina ^b,c   van Hogerlinden, Max ^b   Latonen, Leena ^d   Kyllönen, Lauri ^a   Toftgard, Rune ^b   Saarialho Kere, Ulpu ^a,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cyclosporin; Immunosuppression; Mice; NF B; Skin cancer

Indexed keywords

MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 21; STROMELYSIN 2; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ADULT; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWEN DISEASE; CANCER INVASION; CARCINOMA CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; STROMA CELL;

AGED; AGED, 80 AND OVER; ANIMALS; BOWEN'S DISEASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ENDOTHELIUM; FEMALE; FIBROBLASTS; HUMANS; IMMUNOSUPPRESSION; KERATINOCYTES; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASES, SECRETED; MICE; MICE, TRANSGENIC; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; NEUTROPHILS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN; SKIN NEOPLASMS; STROMAL CELLS;

EID: 70849131193     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00901.x     Document Type: Article

References (56)

1. Goldman G D. Squamous cell cancer: a practical approach. Semin Cutan Med Surg 1998, 17:80-95.
2. Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 2007, 33:1099-1101.
3. Mortier L, Marchetti P, Delaporte E. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett 2002, 176:205-214.
4. Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 2000, 13(Suppl 1):S394-398.
5. Vasudev B, Hariharan S. Cancer after renal transplantation. Curr Opin Nephrol Hypertens 2007, 16:523-528.
6. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003, 348:1681-1691.
7. Ramsay H M, Fryer A A, Reece S, Smith A G, Harden P N. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000, 36:167-176.
8. Harwood C A, Proby C M, McGregor J M, Sheaff M T, Leigh I M, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006, 54:290-300.
9. Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 2003, 16:146-153.
10. Jensen P, Hansen S, Moller B. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40:177-186.
11. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001, 11:S37-43.
12. Lopez-Otin C, Matrisian L M. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007, 7:800-808.
13. Kuivanen T, Jeskanen L, Kyllonen L, Isaka K, Saarialho-Kere U. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared to immunocompetent patients. J Cutan Pathol
14. Vihinen P, Kahari V M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166.
15. Rechardt O, Elomaa O, Vaalamo M. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000, 115:778-787.
16. Krampert M, Bloch W, Sasaki T. Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 2004, 15:5242-5254.
17. Kerkela E, Ala-aho R, Lohi J, Grenman R, M K V, Saarialho-Kere U. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 2001, 84:659-669.
18. Kuivanen T T, Jeskanen L, Kyllonen L, Impola U, Saarialho-Kere U K. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol 2006, 19:1203-1212.
19. Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun 1996, 228:421-429.
20. Kerkela E, Ala-Aho R, Jeskanen L. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 2000, 114:1113-1119.
21. Yang X, Dong Y, Zhao J. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. Pathol Res Pract 2007, 203:499-505.
22. Kerkela E, Ala-aho R, Klemi P. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 2002, 198:258-269.
23. Ahokas K, Lohi J, Lohi H. Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer. Gene 2002, 301:31-41.
24. Marchenko G N, Marchenko N D, Strongin A Y. The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem J 2003, 372:503-515.
25. Ahokas K, Lohi J, Illman S A. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes. Lab Invest 2003, 83:1887-1899.
26. Skoog T, Ahokas K, Orsmark C, Jeskanen L, Isaka K, Saarialho-Kere U. MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture. Exp Dermatol 2006, 15:775-783.
27. Grayson W, Calonje E, McKee P H, McKee P, Calonje E, Granter S. Infectious diseases of the skin. Pathology of the Skin 2005, 840-841. In, eds, Philadelphia, Elsevier Mosby, pp
28. Impola U, Jeskanen L, Ravanti L. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 2005, 152:720-726.
29. Takaishi S, Wang T C. Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Sci 2007, 98:284-293.
30. van Hogerlinden M, Rozell B L, Ahrlund-Richter L, Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 1999, 59:3299-3303.
31. van Hogerlinden M, Rozell B L, Toftgard R, Sundberg J P. Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling. J Invest Dermatol 2004, 123:101-108.
32. Chung C H, Ely K, McGavran L. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 2006, 24:4170-4176.
33. O-charoenrat P, Rhys-Evans P H, Eccles S A. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001, 127:813-820.
34. Euvrard S, Kanitakis J, Decullier E. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006, 81:1093-1100.
35. Siren V, Salmenpera P, Kankuri E. Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med 2006, 38:212-220.
36. Wilkins-Port C E, Higgins P J. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 2007, 185:116-122.
37. Boyd S, Tolvanen K, Virolainen S, Kuivanen T, Kyllonen L, Saarialho-Kere U. Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls. Virchows Arch 2008, 452:83-90.
38. De Angelis T, Noe A, Chatterjee M, Mulholland J. Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma. J Invest Dermatol 2002, 118:759-766.
39. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005, 104:1113-1128.
40. Haider A S, Peters S B, Kaporis H. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006, 126:869-881.
41. Ye H, Yu T, Tenam S. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008, 9:1-11.
42. Mathew R, Khanna R, Kumar R, Mathur M, Shukla N K, Ralhan R. Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 2002, 26:222-228.
43. Bister V, Skoog T, Virolainen S, Kiviluoto T, Puolakkainen P, Saarialho-Kere U. Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma. Mod Pathol 2007, 20:1128-1140.
44. Skoog T, Elomaa O, Pasonen-Seppanen S M. Matrix metalloproteinase-21 expression is associated with keratinocyte differentiation and upregulated by retinoic acid in HaCaT cells. J Invest Dermatol 2009, 129:119-130.
45. Ahokas K, Karjalainen-Lindsberg M L, Sihvo E, Isaka K, Salo J, Saarialho-Kere U. Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer. Tumour Biol 2006, 27:133-141.
46. Lind M H, Rozell B, Wallin R P. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc Natl Acad Sci USA 2004, 101:4972-4977.
47. van Kempen L C, Rhee J S, Dehne K, Lee J, Edwards D R, Coussens L M. Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation 2002, 70:610-623.
48. Page-McCaw A, Ewald A J, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
49. Yarosh D B, Pena A V, Nay S L, Canning M T, Brown D A. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol 2005, 125:1020-1025.
50. Tiu J, Li H, Rassekh C, van der Sloot P, Kovach R, Zhang P. Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine a in carcinogenesis. Laryngoscope 2006, 116:762-769.
51. Madlener M, Mauch C, Conca W, Brauchle M, Parks W C, Werner S. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 1996, 320(Pt 2):659-664.
52. Dazard J E, Gal H, Amariglio N, Rechavi G, Domany E, Givol D. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 2003, 22:2993-3006.
53. Ramos M C, Steinbrenner H, Stuhlmann D, Sies H, Brenneisen P. Induction of MMP-10 and MMP-1 in a squamous cell carcinoma cell line by ultraviolet radiation. Biol Chem 2004, 385:75-86.
54. Saarialho-Kere U, Kerkela E, Jeskanen L. Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage. J Invest Dermatol 1999, 113:664-672.
55. Fogarty G B, Conus N M, Chu J, McArthur G. Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin. Br J Dermatol 2007, 156:92-98.
56. Ding Y, Shimada Y, Gorrin-Rivas M J. Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma. Oncology 2002, 63:378-384.